In TGF-β-driven NSCLC models, loss of Smad3 disrupts SMAD3/SMAD4 complex formation, suppresses Snail expression, and attenuates ECM accumulation, thereby reducing EMT and fibrosis (17, 18). Here, SMAD3 is linked to non-small cell lung carcinoma.